You are here

insulin

FDA panel recommends approval of Novo degludec insulin

Reuters

Thu, 11/8/12 - 09:52 pm

advisory panels

Why Investors Are Voting Against Novo Nordisk

Motley Fool

Wed, 11/7/12 - 11:55 am

advisory panels

FDA staff highlight heart risk with Novo insulin

Reuters

Tue, 11/6/12 - 10:12 am

Lilly to Expand Indianapolis Insulin Manufacturing

Pharma Pro

Fri, 11/2/12 - 10:15 am

drug manufacturing

FDA panel to weigh heart safety of Novo's new insulin

Reuters

Thu, 10/25/12 - 05:33 pm

advisory panels

Novo's long-acting insulin degludec takes big step to megamarket status

Fierce Biotech

Fri, 10/19/12 - 12:20 pm

Hacking Healthcare: Are insulin pumps more susceptible to attack?

Fri, 08/10/12 - 01:11 am

Novo raises targets on Victoza, insulin demand

Yahoo/Reuters

Thu, 08/9/12 - 11:35 am

ADA cancer-risk data clears Sanofi's Lantus

Fierce Pharma

Tue, 06/12/12 - 10:58 am

FDA extends review of Novo Nordisk's Degludec by 3 mths

Reuters

Fri, 06/8/12 - 11:49 am

Sanofi, Novo, Lilly shape up for big insulin fight

Reuters

Wed, 05/30/12 - 10:25 am

Novo’s Insulin Pill Quest Is Holy Grail For Diabetics

Bloomberg

Wed, 05/23/12 - 11:45 am

Novo Nordisk saw strong Q1 insulin competition -CFO

Reuters

Fri, 04/27/12 - 10:19 am

Pfizer's $200 Million Mistake

Motley Fool

Thu, 03/15/12 - 09:11 am

Novo Advances as Pfizer Drops Diabetes Deal

Bloomberg

Tue, 03/13/12 - 11:05 am

Biocon Plunges After Ending Pfizer Insulin Distribution Pact

Bloomberg

Tue, 03/13/12 - 11:03 am

Novo Nordisk (NVO) Owns 55% Of All Insulin Sales With A Patent Stretching To 2022; This Makes Them A Top Pick In Healthcare For The Chairman of Dividend Growth Advisors

Yahoo/Wall St Transcript

Wed, 12/14/11 - 11:02 am

Sanofi’s Lantus Doubled Risk of Cancer in Study of Diabetics

Bloomberg

Tue, 12/6/11 - 07:45 pm

Tandem Diabetes gets FDA OK for smallest available insulin pump system

Wed, 11/16/11 - 10:43 pm

Tandem Diabetes

Exclusive: Medtronic probes insulin pump risks

Tue, 10/25/11 - 10:49 pm

Pages